Form 4 for TRAW Traws Pharma, Inc.
Accepted 2023-02-08 00:00:00 ET · period of report 2023-02-07 · accession 0001415889-23-002171 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-08 | 2023-02-07 | TRAW | Fruchtman Steven M | Pres, CHIEF EXECUTIVE OFF, Dir | M - OptEx | — | +21.3K | 47.5K | +82% | — |
| D | 2023-02-08 | 2023-02-07 | TRAW | Fruchtman Steven M | Pres, CHIEF EXECUTIVE OFF, Dir | F - Tax | $1.36 | -6,977 | 40.5K | -15% | -$9,489 |
| D | 2023-02-08 | 2023-02-07 | TRAW | Fruchtman Steven M | Pres, CHIEF EXECUTIVE OFF, Dir | M - OptEx | $0.00 | -21.3K | 42.6K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-07 | M | A | 21,320 | — | 47,454 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2023-02-07 | F | D | 6,977 | $1.36 | 40,477 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-02-07 | M | D | 21,320 | $0.00 | 42,640 | D | — · — to — | 21,320 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On February 7, 2022 the reporting person was granted 63,960 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary. |